Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Norgine Pharmaceuticals Limited, Norgine House, Widewater place, Moorhall Road, Harefield, Middlesex, U89 6NS, UK
Deponit 5 mg/24 h transdermal patch.
| Pharmaceutical Form |
|---|
|
Transdermal patch. White, translucent square patch with convex round corners with “Deponit 5” marked on the outer face. |
One patch contains glyceryl trinitrate 18.7 mg.
The average amount of glyceryl trinitrate absorbed from each patch in 24 hours is 5 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Glyceryl trinitrate |
Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache. |
| List of Excipients |
|---|
|
Acrylate/vinyl acetate copolymer (adhesive matrix) |
Multilaminate film/foil pouch with heat-sealed edges.
28 patches per carton.
Norgine Pharmaceuticals Limited, Norgine House, Widewater place, Moorhall Road, Harefield, Middlesex, U89 6NS, UK
PL 20011/0044
Date of latest renewal: 28 February 2008
| Drug | Countries | |
|---|---|---|
| DEPONIT | Finland, Italy, Netherlands, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
